Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tuesday broker round-up UPDATE

Tue, 18th Mar 2014 08:58

Antofagasta: Investec places its target price (prev.: 753p) under review, while leaving its sell recommendation unchanged.Ashtead Group: Credit Suisse raises target price from 1000p to 1100p and stays with its outperform rating. UBS increases target price from 875p to 1020p retaining its buy recommendation.ASOS: Panmure Gordon raises target price from 6051p to 6126p and leaves its hold recommendation unaltered.BAE Systems: RBC Capital ups target price from 450p to 490p and upgrades to outperform.Berkeley Group: Numis raises target price to 3000p and upgrades from hold to add.Bioquell: Investec lowers target price from 147p to 133p and stays with its hold recommendation.Bunzl: JP Morgan shifts target price from 1516p to 1520p and reiterates a neutral rating.Capital Drilling: Liberum Capital moves target price from 35p to 40p and stays with its buy recommendation.Close Brothers Group: JP Morgan increases target price from 1480p to 1512p and stays with its overweight rating.CSR: UBS raises target price from 580p to 750p, while its neutral rating remains unchanged.Exillon Energy: Investec places both its target price (prev.: 270p) and its buy recommendation under review.Glencore Xstrata: RBC Capital ups target price from 350p to 375p and leaves its outperform rating unchanged.Great Portland Group: UBS raises target price from 670p to 705p leaving its buy recommendation unaltered.Gulf Keystone Petroleum: Cantor Fitzgerald cuts target price from 183p to 154p and maintains a buy recommendation.Hikma Pharmaceuticals: Bank of America raises target price from 1600p to 1750p staying with its neutral rating.IG Group: Canaccord Genuity takes target price from 666p to 711p and retains a buy recommendation.Japan Residential Investment: Liberum Capital lowers target price from 74p to 68p and leaves its buy recommendation unchanged.Mears Group: Investec increases target price from 495p to 520p and retains an add rating.Mecom: Numis shifts target price from 150p to 155p and keeps a buy recommendation. Canaccord Genuity shifts target price from 150p to 158p maintaining a buy recommendation.Pearson: Numis reduces target price from 1189p to 1048p and leaves its hold recommendation unaltered.Pittards: WH Ireland ups target price from 230p to 270p and keeps a buy recommendation.Premier Foods: UBS takes target price from 65p to 115p, but still recommends selling.Redefine International: Deutsche Bank moves target price from 38.3p to 51p, but downgrades to hold.Royal Bank of Scotland: RBC Capital reduces target price from 310p to 250p and keeps its underperform rating.RSA Insurance: Berenberg cuts target price from 112p to 92.6p retaining its hold recommendation.Sainsbury: JP Morgan reduces target price from 340p to 280p and stays with its underweight rating. Panmure Gordon cuts target price from 400p to 320p retaining its hold recommendation.Schroders: Credit Suisse raises target price from 2810p to 2900p reiterating its neutral rating.SDL: Panmure Gordon moves target price from 410p to 421p maintaining a buy recommendation. Canaccord Genuity increases target price from 266p to 325p retaining a hold recommendation.Shore Capital: RBC Capital raises target price from 300p to 450p and maintains its outperform rating.SIG: Deutsche Bank shifts target price from 182p to 190p reiterating its hold recommendation.Spirax-Sarco Engineering: Investec reduces target price from 3425p to 3210p, while keeping its buy recommendation.TUI Travel: Barclays ups target price from 445p to 500p reiterating an overweight rating.UNITE: Jefferies raises target price from 465p to 497p and retains a buy recommendation.
More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.